Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502

MLA

Seiichiro Mitani, et al. “Second Primary Malignancies in Patients with Clinical T1bN0 Esophageal Squamous Cell Carcinoma after Definitive Therapies: Supplementary Analysis of the JCOG Trial: JCOG0502.” Journal of Gastroenterology, vol. 57, no. 7, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....65cec8a8f52c12eae14883ae994754e0&authtype=sso&custid=ns315887.

APA

Seiichiro Mitani, Ken Kato, Hiroyuki Daiko, Yoshinori Ito, Isao Nozaki, Takashi Kojima, Masahiko Yano, Satoru Nakagawa, Masaki Ueno, Masaya Watanabe, Shigeru Tsunoda, Tetsuya Abe, Shigenori Kadowaki, Tomohiro Kadota, Keita Sasaki, Ryunosuke Machida, & Yuko Kitagawa. (2021). Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502. Journal of Gastroenterology, 57(7).

Chicago

Seiichiro Mitani, Ken Kato, Hiroyuki Daiko, Yoshinori Ito, Isao Nozaki, Takashi Kojima, Masahiko Yano, et al. 2021. “Second Primary Malignancies in Patients with Clinical T1bN0 Esophageal Squamous Cell Carcinoma after Definitive Therapies: Supplementary Analysis of the JCOG Trial: JCOG0502.” Journal of Gastroenterology 57 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....65cec8a8f52c12eae14883ae994754e0&authtype=sso&custid=ns315887.